Innate Pharma (IPHA) Pension (2017 - 2025)

Innate Pharma (IPHA) has reported Pension for 9 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.

• Quarterly Pension fell 29.56% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (down 29.56% YoY) and the FY2025 annual result came in at $2.2 million, down 29.56% from the prior year.
• Pension retreated to $2.2 million in Q4 2025 per IPHA's latest filing, from $3.0 million in the prior quarter.
• Over the last five years, Pension for IPHA reached as high as $4.4 million in Q2 2021 and fell as low as $2.2 million in Q4 2025.
• A 5-year average of $3.1 million and a median of $3.0 million in 2022 frame the typical range for Pension.
• Annual changes were most pronounced in 2021 — Pension tumbled 99.89% — and 2024, when it rose 11.84%.
• Year by year, Pension stood at $3.4 million in 2021, then retreated by 14.29% to $2.9 million in 2022, then slipped by 4.27% to $2.8 million in 2023, then advanced by 11.84% to $3.1 million in 2024, then dropped by 29.56% to $2.2 million in 2025.
• According to Business Quant data, Pension over the past three periods registered $2.2 million, $3.0 million, and $3.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.